1677P Pancreatic enzyme replacement therapy improves survival in patients receiving nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma
- Resource Type
- Abstract
- Source
- In
Annals of Oncology October 2023 34 Supplement 2:S920-S920 - Subject
- Language
- ISSN
- 0923-7534